Filling Gaps in Asthma Care: Alkem’s Innovative Solution
Alkem, a pioneer in healthcare solutions, has unveiled Innohaler, a revolutionary Dry Powder Inhaler (DPI) device, as a response to this year’s World Asthma Day theme – ‘Closing Gaps in Asthma Care’. This innovative step addresses the challenges faced by Asthma and Chronic Obstructive Pulmonary Disease (COPD) patients, working to bridge existing gaps in respiratory care in India.
Addressing the Burden of Obstructive Airway Diseases
Obstructive Airway Diseases (OADs) such as Asthma and COPD contribute significantly to the health burden in India. Startling statistics reveal that out of approximately nine crore OAD patients, less than one crore have access to appropriate lung care. This underscores the pressing need for improved accessibility and effective treatment options.
Empowering Patients with Innovative Drug Delivery
The delicate nature of the lungs makes them prone to various diseases, including Asthma and COPD. Alkem’s introduction of Innohaler as a preferred Dry Powder Inhaler (DPI) device marks a significant advancement in the field. This step aims to ensure optimal drug delivery, ultimately alleviating the challenges faced by patients and improving their quality of life.
Elevating Pulmonology Solutions: Alkem’s Vision
The launch of Innohaler signifies Alkem’s strategic foray into the core of inhalation therapeutics. The device’s introduction exemplifies Alkem’s commitment to revolutionizing the pulmonology vertical, ensuring that patients receive the right care and knowledge, leading to better treatment outcomes.
Sandeep Singh’s Vision: Reducing Lung Burden
Sandeep Singh, Managing Director of Alkem Laboratories Ltd., emphasized the transformative impact of Innohaler, stating, “This moment is like fulfilling our promise to millions deprived of the right care in obstructive airway diseases and a reminder that we have to travel many miles further.” This launch reflects Alkem’s dedication to reducing the respiratory disease burden in India.